Cargando…
Selective Elimination of Osteosarcoma Cell Lines with Short Telomeres by Ataxia Telangiectasia and Rad3-Related Inhibitors
[Image: see text] To avoid replicative senescence or telomere-induced apoptosis, cancers employ telomere maintenance mechanisms (TMMs) involving either the upregulation of telomerase or the acquisition of recombination-based alternative telomere lengthening (ALT). The choice of TMM may differentiall...
Autores principales: | Goncalves, Tomas, Zoumpoulidou, Georgia, Alvarez-Mendoza, Carlos, Mancusi, Caterina, Collopy, Laura C., Strauss, Sandra J., Mittnacht, Sibylle, Tomita, Kazunori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737214/ https://www.ncbi.nlm.nih.gov/pubmed/33344901 http://dx.doi.org/10.1021/acsptsci.0c00125 |
Ejemplares similares
-
Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma
por: Zoumpoulidou, Georgia, et al.
Publicado: (2021) -
Quantitative Phosphoproteomics of the Ataxia Telangiectasia-Mutated (ATM) and Ataxia Telangiectasia-Mutated and Rad3-related (ATR) Dependent DNA Damage Response in Arabidopsis thaliana
por: Roitinger, Elisabeth, et al.
Publicado: (2015) -
Clinicopathological significance of ataxia telangiectasia-mutated (ATM) kinase and ataxia telangiectasia-mutated and Rad3-related (ATR) kinase in MYC overexpressed breast cancers
por: Savva, Constantinos, et al.
Publicado: (2019) -
Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells
por: Jette, Nicholas R., et al.
Publicado: (2019) -
Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families
por: Renault, Anne-Laure, et al.
Publicado: (2017)